Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 74,882	$ 46,339
Short-term investments	96,464	150,917
Accounts receivable, net	38,367	11,804
Inventory	35,313	27,886
Prepaid expenses and other current assets	46,553	31,360
Total current assets	291,579	268,306
Restricted cash	745	737
Long-term investments	5,012	5,482
Property and equipment, net	82,423	85,365
Goodwill	67,595	1,931
Developed technology - on-body infusor	190,027
IPR&D - ReadyFlow Formulation	129,600
Other intangible assets	5,072	5,265
Other assets	20,129	26,757
Total assets	792,182	393,843
Current liabilities:
Accounts payable	9,034	6,792
Accrued expenses and other current liabilities	64,628	40,293
Senior convertible notes - current	36,280
Liability for sale of future royalties - current	14,298	12,283
Contingent consideration - current	21,132
Financing liability - current	10,328	10,062
Deferred revenue - current	15,331	12,407
Total current liabilities	171,031	81,837
Liability for sale of future royalties - long term	136,985	137,362
Financing liability - long term	93,092	93,877
Deferred revenue — long term	39,977	51,160
Recognized loss on purchase commitments — long term	65,952	58,204
Operating lease liability	10,689	11,645
Contingent consideration -long term	5,114
Milestone liabilities	2,003	2,523
Term loan	318,361
Senior convertible notes		36,051
Total liabilities	843,204	472,659
Commitments and contingencies (Note 14)
Stockholders' deficit:
Undesignated preferred stock, $0.01 par value - 10,000,000 shares authorized; no shares issued or outstanding as of December 31, 2025 or December 31,2024
Common stock, $0.01 par value - 800,000,000 shares authorized; 307,832,587 and 302,959,782 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively	3,078	3,029
Additional paid-in capital	3,141,741	3,118,865
Accumulated other comprehensive income	115	1,109
Accumulated deficit	(3,195,956)	(3,201,819)
Total stockholders' deficit	(51,022)	(78,816)
Total liabilities and stockholders' deficit	$ 792,182	$ 393,843